Govt Proposes Relaxing Schedule M Requirements for Medicinal Gases, Capsules and Disinfectants
New Delhi: The Ministry of Health and Family Welfare has proposed allowing licensing authorities to modify Schedule M requirements for certain products, including medicinal gases, empty gelatin capsules and disinfectant fluids, where the Schedule does not prescribe specific space and equipment requirements.
The proposed changes would be considered case by case, with reasons recorded in writing. The proposal is set out in draft notification G.S.R. 985(E), dated November 6, 2026. It seeks to insert a note at the end of Part XIII of Schedule M of the Drugs Rules, 1945.
Under the proposed note, the Licensing Authority or Central Licence Approving Authority, as applicable, could relax or alter Schedule M requirements after considering the nature of the product and the extent of its manufacturing operations. The authority would have to record its reasons in writing.
The draft also provides that the authority may direct a manufacturer to carry out necessary modifications and approve manufacture after those modifications have been made. It does not provide an automatic exemption for the products named in the note.
The draft stated:
"1. (i) These rules may be called the Drugs (...... Amendment) Rules, 2026.(ii) They shall come into force on the date of their final publication in the Official Gazette.2. In the Drugs Rules, 1945, under the Schedule M, at the end of Part XIII, the following Note shall be inserted.Note: - There are certain categories of drugs such as medicinal gases, empty gelatin capsules, and disinfectant fluids for which this Schedule does not prescribe specific requirements of space and equipments. The Licensing Authority or Central Licence Approving Authority, as the case may be, in respect of such categories of drugs, have the discretion to modify the requirements of this Schedule, if he is of the opinion that having regard to the nature of the products and extent of manufacturing operations and for reasons to be recorded in writing, it is necessary to relax or alter them in the circumstances of a particular case and direct the manufacturer to carry out necessary modifications in them and the modifications having been made, approve the manufacture of such categories of the drugs."
The draft was published after consultation with the Drugs Technical Advisory Board under Sections 12(1) and 33(1) of the Drugs and Cosmetics Act, 1940.
The Central Government will consider objections and suggestions received within 30 days from the date copies of the Gazette containing the draft rules are made available to the public. Submissions may be addressed to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Kartavya Bhawan-1, New Delhi–110011, or sent to the email address stated in the notification.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.